Korea vs Ukraine: The number of people with susceptibility test result for rifampicin
Korea
9,284
in 2021
Ukraine
9,237
in 2021
Korea rank
22nd
Ukraine rank
23rd
The number of people with susceptibility test result for rifampicin over time
- Korea
- Ukraine
How they compare
Korea currently reports 9,284 against 9,237 in Ukraine, a difference of 47.
Across all 5 years both countries report, Korea has been ahead every year.
Korea ranks 22nd and Ukraine ranks 23rd of 155 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13,475 | 12,368 | 1,107 | Korea |
| 2020s | 9,936 | 9,015 | 921.5 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Korea or Ukraine?
- Korea, at 9,284 against 9,237 in Ukraine as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Korea and Ukraine?
- 47, with Korea ahead.
- How many years of comparable data are there for Korea and Ukraine?
- 5 years are reported by both, from 2017 to 2021.
- How do Korea and Ukraine rank globally for the number of people with susceptibility test result for rifampicin?
- Korea ranks 22nd and Ukraine ranks 23rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.